Sort
15,842 grants matching “pancreatic cancer”
The CCK-B receptor signaling pathway as a driver of pancreatic cellular plasticity and carcinogenesis
$562,784Jill P Smith · Georgetown University · R01 · FY2024 · CA
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
$562,648Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U01 · FY2014 · CA
Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression
$562,581Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2023 · CA
Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression
$562,581Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2022 · CA
Dietary fatty acids drive pancreatic cancer development
$562,558Mandar Deepak Muzumdar · Yale University · R01 · FY2025 · CA
ROS-targeted therapy for pancreatic cancer
$562,471Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
ROS-targeted therapy for pancreatic cancer
$562,471Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Project 1
$562,281David J Odde · University Of Minnesota · P01 · FY2025 · CA
Studies of Materials with Physiological Properties
$562,258Harvard University · R01 · FY2005 · GM
Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$562,229Sanku Mallik · North Dakota State University · P20 · FY2023 · GM
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
$562,163Julie R Palmer · Boston University Medical Campus · U01 · FY2016 · CA
Identification of key tumor cell-released factors that induce cachexia
$562,022Yi-Ping Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · AR
Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer
$561,772Andrew James Aguirre · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer
$561,772Andrew James Aguirre · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$561,734David G Denardo · Washington University · R01 · FY2024 · CA
Genome-wide Copy Number Variation and Breast Cancer Risk
$561,690Jirong Long · Vanderbilt University · R01 · FY2012 · CA
Biomarkers for the Early Detection of Pancreatic Cancer
$561,227Ann M Killary · University Of Tx Md Anderson Can Ctr · U01 · FY2013 · CA
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
$561,181Debabrata Mukhopadhyay · Mayo Clinic Jacksonville · R01 · FY2019 · CA
Macropinocytosis Inhibition as a Glutamine Mimetic Sensitization Strategy in Pancreatic Cancer
$561,077Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
TARGETING HEPATOCYTE-DERIVED FACTORS TO IMPROVE THE EFFICACY OF IMMUNOTHERAPY IN PANCREATIC CANCER
$560,870Trustees Of The University Of Pennsylvania, The · · FY2021 · Department of the Army
Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan)
$560,680Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
$560,492David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2016 · CA
Immune cell control of ovarian cancer
$560,328Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens
$560,027Rosalie C Sears · Oregon Health & Science University · U01 · FY2020 · CA
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
$559,976Anirban Maitra · University Of Tx Md Anderson Can Ctr · U24 · FY2021 · CA